Última Hora: "'Titín III': «Ni Otegi es mi amigo ni mucho menos comulgo con sus ... - El Correo Digital (Vizcaya)" Thu, 24 May 2012 01:34:16 GMT    "La caída de Grecia, un peligro para todos los socios - Cinco Días" Thu, 24 May 2012 00:06:26 GMT    "Economía prohibirá que las preferentes se vendan íntegramente a ... - Lainformacion.com" Wed, 23 May 2012 19:40:42 GMT    "Guindos se compromete a aportar todo el capital que requiera Bankia - Cinco Días" Thu, 24 May 2012 00:11:21 GMT   "Rajoy respeta la independencia del BCE pero cree capital que ... - La Vanguardia" Thu, 24 May 2012 00:41:07 GMT    "Nissan invertirá en dos años 300 millones en España - Cinco Días" Thu, 24 May 2012 00:11:41 GMT    "2013: la hora de la recuperación - La Razón" Thu, 24 May 2012 01:40:29 GMT    "Fianza de 807 millones para el ex consejero de los ERE - La Razón" Thu, 24 May 2012 01:31:47 GMT    "Inversores de Facebook demandan a la compañía y a sus colocadores ... - Cinco Días" Thu, 24 May 2012 00:11:40 GMT    "Sigue la movilización callejera - El Correo Digital (Vizcaya)" Thu, 24 May 2012 00:29:23 GMT      Para más noticias, haga clic aquí.

Zona de Acceso
       
       
¿Recordarme? 

Bajada de
-0,880 (-3.30%%) Amylin Pharmaceut - [Ticker: AMLN]Gráfico Amylin Pharmaceut  Noticias Amylin Pharmaceut  Descargar Históricos de Metastock Amylin Pharmaceut y Otros  Análisis Técnico Amylin Pharmaceut  
Última Transacción25,810Hora de Cotización2012-05-23 - 21:00
Variación-0,880 (-3.30%)Rango 52 Semanas[8,030 - 26,870]
Máximo26,540Mínimo24,970
Volumen5.748.542Volumen Medio (3m)4.174.050
Demanda / Oferta25,700 x 100 - 26,290 x 200YieldN/A
Cierre Anterior26,690PER0,00%
Apertura26,490EPS-4,11
Fecha Ex-DividendoN/AFecha DividendoN/A
Capitalización Bursátil4 Objetivo Estimado 1 Año19,840
Nota: Los datos pueden tener un retraso de algunos minutos.
Ver cotizaciones de otros activos

Intradía   5 días   1 mes   3 meses   6 meses   1 año   2 años   5 años   10 años            Utilice este gráfico en su sitio web!
Gráfico de Amylin Pharmaceut -  [Ticker: AMLN]
Cambiar para Gráfico Interactivo de Análisis Técnico de Amylin Pharmaceut

Últimos 10 Tópicos en el Foro relacionados con Amylin Pharmaceut:
No se han encontrado tópicos relacionados con Amylin Pharmaceut [AMLN], pero se aconseja la búsqueda en el Foro para tópicos relacionados con Amylin Pharmaceut.

 Noticias de Amylin Pharmaceut [AMLN]:   (ordenadas por relevancia)

Bloomberg

Amylin Said to Attract Interest From Pfizer, AstraZeneca
BusinessWeek
By Jeffrey McCracken, Albertina Torsoli and Meg Tirrell on May 15, 2012 Amylin Pharmaceuticals Inc. (AMLN) (AMLN) has lured suitors such as Pfizer Inc. (PFE) (PFE), AstraZeneca Plc (AZN) and Sanofi, which signed confidentiality agreements on the ...
This Biotech's for Sale! Reportedly.DailyFinance
Amylin (AMLN) Attracting a Host of Other Suitors, Shares RiseStreetInsider.com (subscription)
Amylin said to be attracting several Big Pharma suitorsThe Pharma Letter

los 10 artículos informativos »

Lilly's GLP-1 Agonist Delivers
Zacks.com
While approved products include Novo Nordisk's (NVO - Snapshot Report) Victoza and Amylin's (AMLN - Analyst Report) Bydureon and Byetta, companies like GlaxoSmithKline (GSK - Analyst Report) and Sanofi (SNY - Analyst Report) have GLP-1 candidates in ...
Lilly's GLP-1 Agonist Delivers - Analyst BlogNASDAQ

los 9 artículos informativos »

Spectacular Reversal Off Lows
FXstreet.com
(IBM) did lose 70 cents to 196.12, and Amylin Pharmaceuticals, Inc. (AMLN) was down 88 cents to 25.81. Stepping back and reviewing the hourly chart patterns, the indices were down early in declining wedge patterns to retest lows of earlier in the week.

y más »

Bloomberg

Amylin climbs 6% on buyout speculation
MarketWatch
BOSTON (MarketWatch) -- Shares of Amylin Pharmaceuticals (US:amln) climbed 6% in early trading Tuesday after analysts at Leerink Swann said they see Sanofi (US:sny) and Merck (US:mrk) emerging as the strongest bidders for the biotech firm, ...
Amylin Goes A Little Wizard Of Oz On ShareholdersSeeking Alpha
Big-name pharmas peer at Amylin's books to prep for bidsFiercePharma
Buzz: Big Pharma suitors line up for a look at Amylin's booksFierceBiotech

los 17 artículos informativos »

Bloomberg

XBI, HGSI, AMLN, INCY: ETF Inflow Alert
Forbes
Among the largest underlying components of XBI, in trading today Human Genome Sciences Inc. (NASD: HGSI) is up about 0.5%, Amylin Pharmaceuticals, Inc. (NASD: AMLN) is off about 0.8%, and Incyte Corporation (NASD: INCY) is lower by about 2.5%.
Guide to the 25 Cheapest ETFs - ETF News And CommentaryNASDAQ

los 164 artículos informativos »

Allscripts sued by shareholder, seeks proxy fight
Reuters
Billionaire investor Carl Icahn scored a victory with a similar lawsuit last month in his push to have Amylin Pharmaceuticals (AMLN.O) put up for sale. Icahn sued the company in the same Delaware court, arguing Amylin's similar advance notice bylaws ...

y más »

Did You Buy These Stocks?
NASDAQ
Shares of Amylin Pharmaceuticals Inc. (AMLN) were trading around $10 when we alerted readers to the stock last December, and based on Tuesday's closing price of $26.69, it is up nearly 155%. The stock touched a 52-week high of $28.02 on May 16, 2012.

y más »

DHI, DFG, LEN, AMLN, DF Hit New 52-Week Highs
The Mumbai Times
The 13 analysts offering 12-month price forecasts for Amylin Pharmaceuticals Inc have a median target of 22.00, with a high estimate of 32.00 and a low estimate of 8.00. The median estimate represents a -19.41% decrease from the last price of 27.30.
LEN, AMLN, ARIA, TRIP, KMB Hit New 52-Week HighsFyxnews

los 4 artículos informativos »

Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
MarketWatch (press release)
SAN DIEGO, May 08, 2012 (BUSINESS WIRE) -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will webcast its Annual Meeting of Stockholders on Tuesday, May 15, 2012 at 9:00 am PT/ 12:00 pm ET from the Company's corporate headquarters in San Diego.

y más »

Amylin Pharmaceuticals (AMLN) - Daily Volume Update
AVAFIN
Shares of Amylin Pharmaceuticals rose $1.65 (+6.43%) to $27.30 in today's trading session. The price of AMLN ranged between $26.65 - $27.40. Volume is 8M in relation to the three month average volume of 4M shares. AMLN is trading above the 50 day ...


Amylin Said to Attract Interest From Pfizer, AstraZeneca
Bloomberg
Deals Amylin Said to Attract Pfizer, AstraZeneca, Sanofi in Sale Amylin Pharmaceuticals Inc. (AMLN) has lured suitors such as Pfizer Inc., AstraZeneca Plc and Sanofi (SAN), which signed confidentiality agreements on the drugmaker's sale process, ...

y más »

Dividend.com

Colgate-Palmolive, Amylin Pharmaceuticals, Other Stocks Hit 52-Week Highs Tuesday
Fox Business
The share price of Amylin Pharmaceuticals (AMLN) climbed today, reaching and then surpassing its previous 52-week high of $26.87. The stock was trading on above-average volume. The stock price has gained 6.4% with 5.4 million shares moving.
Highs & Lows: Amylin Pharmaceuticals, Colgate-Palmolive, and EricssonSchaeffers Research (blog)

los 11 artículos informativos »

Bloomberg

Come On, Amylin, Just a Little Clue?
DailyFinance
By Brian Orelli, The Motley Fool Maybe Amylin Pharmaceuticals (NAS: AMLN) thinks that letting investors read between the lines is good enough, but I think they deserve a little more. Last month, Bloomberg reported that Bristol-Myers Squibb (NYS: BMY) ...
Amylin Pharma Q1 Loss WidensNASDAQ
The Drama Continues At Amylin Pharmaceuticals: Takeover Still LikelySeeking Alpha
Amylin operating loss leaps to over $30 millionThe Pharma Letter

los 71 artículos informativos »

Our Take: CSOD, VOXX, FSLR, VRX Among Charts to Watch
The Mumbai Times
Amylin Pharmaceuticals Inc (NASDAQ:AMLN) shares were trading at $27.30 while reporting up 6.43% from yesterdays close. The 13 analysts offering 12-month price forecasts for Amylin Pharmaceuticals Inc have a median target of 22.00, with a high estimate ...


Wider Loss at Amylin
Zacks.com
Amylin Pharmaceuticals (AMLN - Analyst Report) reported a first quarter loss of 58 cents per share, wider than the year-ago loss of 24 cents. First quarter revenues, which increased 0.6% to $153.7 million, were well below the Zacks Consensus Estimate ...

y más »
Para más noticias de Amylin Pharmaceut hacer clic aquí:
Noticias de Amylin Pharmaceut

Anchura de la Página:

 Imagen de Fondo:

Copyright@2009-2012 - BolsaES.com, todos los derechos reservados.
Foro de Bolsa Cotizaciones Noticias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters